Nothing Special   »   [go: up one dir, main page]

SE9501056D0 - Epithelial adherent lactobacilli - Google Patents

Epithelial adherent lactobacilli

Info

Publication number
SE9501056D0
SE9501056D0 SE9501056A SE9501056A SE9501056D0 SE 9501056 D0 SE9501056 D0 SE 9501056D0 SE 9501056 A SE9501056 A SE 9501056A SE 9501056 A SE9501056 A SE 9501056A SE 9501056 D0 SE9501056 D0 SE 9501056D0
Authority
SE
Sweden
Prior art keywords
pct
mannose
date sep
sec
strain
Prior art date
Application number
SE9501056A
Other languages
English (en)
Inventor
Ingegerd Adlerberth
Siv Ahrne
Bengt Jeppson
Marie-Louise Johansson
Goeran Molin
Agnes Wold
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Priority to SE9501056A priority Critical patent/SE9501056D0/sv
Publication of SE9501056D0 publication Critical patent/SE9501056D0/sv
Priority to PL96322550A priority patent/PL184037B1/pl
Priority to JP52834796A priority patent/JP4072646B2/ja
Priority to AU51665/96A priority patent/AU702705B2/en
Priority to KR1019970706504A priority patent/KR100446482B1/ko
Priority to EE9700329A priority patent/EE04097B1/xx
Priority to CA002216150A priority patent/CA2216150C/en
Priority to PCT/SE1996/000372 priority patent/WO1996029083A1/en
Priority to EP96908428A priority patent/EP0817640B1/en
Priority to ES96908428T priority patent/ES2200057T3/es
Priority to AT96908428T priority patent/ATE240738T1/de
Priority to BR9607538A priority patent/BR9607538A/pt
Priority to US08/913,618 priority patent/US6159465A/en
Priority to CNB961940867A priority patent/CN1138551C/zh
Priority to DE69628288T priority patent/DE69628288T2/de
Priority to NO974371A priority patent/NO974371L/no
Priority to HK98111312A priority patent/HK1017989A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SE9501056A 1995-03-23 1995-03-23 Epithelial adherent lactobacilli SE9501056D0 (sv)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE9501056A SE9501056D0 (sv) 1995-03-23 1995-03-23 Epithelial adherent lactobacilli
DE69628288T DE69628288T2 (de) 1995-03-23 1996-03-25 Verwendung von epithel-adhärente lactobazillen
CA002216150A CA2216150C (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
EP96908428A EP0817640B1 (en) 1995-03-23 1996-03-25 Use of epithelial adhesive lactobacilli
AU51665/96A AU702705B2 (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
KR1019970706504A KR100446482B1 (ko) 1995-03-23 1996-03-25 상피흡착성락토바실러스
EE9700329A EE04097B1 (et) 1995-03-23 1996-03-25 Epiteliaal-adhesiivsed laktobatsillid
PL96322550A PL184037B1 (pl) 1995-03-23 1996-03-25 Zastosowanie Lactobacillus plantarum
PCT/SE1996/000372 WO1996029083A1 (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
JP52834796A JP4072646B2 (ja) 1995-03-23 1996-03-25 上皮接着性乳酸桿菌
ES96908428T ES2200057T3 (es) 1995-03-23 1996-03-25 Uso de lactobacillus como adhesivo epitelial.
AT96908428T ATE240738T1 (de) 1995-03-23 1996-03-25 Verwendung von epithel-adhärente lactobazillen
BR9607538A BR9607538A (pt) 1995-03-23 1996-03-25 Lactobacilos aderentes ao epitélio
US08/913,618 US6159465A (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
CNB961940867A CN1138551C (zh) 1995-03-23 1996-03-25 上皮粘附性乳杆菌
NO974371A NO974371L (no) 1995-03-23 1997-09-22 Epitelialadhesive lactobacilli
HK98111312A HK1017989A1 (en) 1995-03-23 1998-10-19 Epithelial adhesive lactobacilli

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501056A SE9501056D0 (sv) 1995-03-23 1995-03-23 Epithelial adherent lactobacilli

Publications (1)

Publication Number Publication Date
SE9501056D0 true SE9501056D0 (sv) 1995-03-23

Family

ID=20397666

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9501056A SE9501056D0 (sv) 1995-03-23 1995-03-23 Epithelial adherent lactobacilli

Country Status (17)

Country Link
US (1) US6159465A (sv)
EP (1) EP0817640B1 (sv)
JP (1) JP4072646B2 (sv)
KR (1) KR100446482B1 (sv)
CN (1) CN1138551C (sv)
AT (1) ATE240738T1 (sv)
AU (1) AU702705B2 (sv)
BR (1) BR9607538A (sv)
CA (1) CA2216150C (sv)
DE (1) DE69628288T2 (sv)
EE (1) EE04097B1 (sv)
ES (1) ES2200057T3 (sv)
HK (1) HK1017989A1 (sv)
NO (1) NO974371L (sv)
PL (1) PL184037B1 (sv)
SE (1) SE9501056D0 (sv)
WO (1) WO1996029083A1 (sv)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
FI974643A (sv) * 1997-12-30 1999-07-01 Atria Oyj Biologiskt förfarande för elimination av salmonella ur processer och konstruktioner
AU764011B2 (en) * 1998-10-01 2003-08-07 Probi Ab Reduction of oxidative stress factors
EP1212066A4 (en) * 1999-08-09 2004-03-03 Univ Maryland PROINTESTINAL MATURATION AND ANTI-INFLAMMATORY EFFECTS OF LACTOBACILLUS AS WELL AS PROTEINS, CARBOHYDRATES AND LIPIDS SECRETED BY LACTOBACILLUS
MXPA02004115A (es) 1999-10-26 2002-10-17 Nestle Sa Bacterias acidolacticas para el tratamiento o profilaxis de giardiasis.
GB2369777B (en) * 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
SE0004124D0 (sv) * 2000-11-10 2000-11-10 Probi Ab New use
FR2831555A1 (fr) * 2001-10-29 2003-05-02 Ceva Sante Animale Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes
FR2826020B1 (fr) * 2001-06-14 2005-02-11 Ceva Sante Animale Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes
PL364429A1 (en) * 2001-06-14 2004-12-13 Ceva Sante Animale Method of selecting non-pathogenic gram-positive lactic acid bacteria strains
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2005086870A2 (en) * 2004-03-10 2005-09-22 The Board Of Trustees Of The University Of Illinois Novel lactobacillus strains and method of use
DE602005020915D1 (de) * 2004-03-23 2010-06-10 Friesland Brands Bv Mannose-spezifische adhesinen und deren vervendung
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
JP2006180836A (ja) * 2004-12-28 2006-07-13 Marudai Food Co Ltd 食中毒菌感染を抑制する乳酸菌、ならびにそれを含む発酵物、食品および医薬組成物
JP2006257077A (ja) * 2005-02-18 2006-09-28 Marudai Food Co Ltd 免疫調節剤および免疫調節食品
CN1888051B (zh) * 2005-06-28 2010-05-05 北京天佑达生物工程科技有限公司 一株植物乳杆菌及其应用
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption
EP3067057B1 (en) * 2005-09-28 2022-11-09 Nordic Rebalance A/S Probiotic fermented cereal compositions for use in treatment of gastrointestinal disorders caused by pro-inflammatory bacteria
US9173989B2 (en) 2005-12-13 2015-11-03 Exthera Medical Corporation Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
PL210465B1 (pl) 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
FR2928935B1 (fr) 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
EP2459203B1 (en) * 2009-07-30 2018-10-31 DuPont Nutrition Biosciences ApS Lactic acid bacteria and bifidobacteria for treating endotoxemia
JP5925693B2 (ja) 2009-12-01 2016-05-25 エクステラ・メディカル・コーポレーション 表面固定した多糖類を用いた、血液からのサイトカイン除去法
MY162344A (en) 2010-01-28 2017-06-15 Ab-Biotics S A Probiotic composition for use in the treatment of bowel inflammation
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
BG66608B1 (bg) * 2011-05-04 2017-10-16 "Ел Би Булгарикум" ЕАД Полибактериален пробиотичен препарат
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
ES2647577T3 (es) 2012-06-13 2017-12-22 Exthera Medical Corporation Uso de heparina y carbohidratos para tratar el cáncer
JP2012184261A (ja) * 2012-06-21 2012-09-27 Snow Brand Milk Products Co Ltd 免疫増強剤
CN102827796B (zh) * 2012-09-03 2013-10-30 江南大学 一种具有排镉功能的植物乳杆菌及其用途
EP2897638A1 (en) * 2012-09-24 2015-07-29 Montana State University-Bozeman Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use
AU2014302884B2 (en) * 2013-06-24 2018-03-29 Exthera Medical Corporation Blood filtration system containing mannose coated substrate
CN105705177B (zh) 2013-11-08 2019-10-22 艾克塞拉医疗公司 使用吸附介质诊断感染性疾病的方法
ES2625351T1 (es) 2014-04-24 2017-07-19 Exthera Medical Corporation Método para eliminar bacterias de la sangre utilizando caudal alto
JP7100454B2 (ja) 2014-09-22 2022-07-13 エクスセラ メディカル コーポレイション 装着型血液潅流デバイス
KR102587444B1 (ko) 2015-09-29 2023-10-11 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승 조성물
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
EP3422943A4 (en) 2016-03-02 2019-10-16 ExThera Medical Corporation METHOD OF TREATING DRUG ENTRIES
GB2574534B (en) 2017-02-28 2022-06-08 Kimberly Clark Co Synergistic composition for maintenance of healthy balance of microflora
KR102024883B1 (ko) 2017-11-24 2019-09-24 주식회사 고바이오랩 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도
SG11202010944RA (en) 2018-05-09 2020-12-30 Ko Biolabs Inc Lactobacillus paracasei strain and use thereof
AU2019274351B2 (en) 2018-05-23 2022-04-07 Kobiolabs, Inc. Lactobacillus gasseri KBL697 strain and use thereof
CA3137294A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure
JP7303296B2 (ja) 2019-06-05 2023-07-04 森永乳業株式会社 栄養組成物
CN111575223B (zh) * 2020-05-20 2022-04-15 江南大学 一种降低鼠李糖乳杆菌表面物质分泌量的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203586A3 (en) * 1985-05-29 1988-03-09 Pioneer Hi-Bred International A composition for treating gastrointestinal disease in animals
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
GB9124249D0 (en) * 1991-11-14 1992-01-08 Goldstein Fredric Ribbon curling and shredding device
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection

Also Published As

Publication number Publication date
CA2216150A1 (en) 1996-09-26
KR19980703102A (ko) 1998-10-15
EE04097B1 (et) 2003-08-15
DE69628288T2 (de) 2004-04-08
ATE240738T1 (de) 2003-06-15
DE69628288D1 (de) 2003-06-26
KR100446482B1 (ko) 2006-01-27
PL184037B1 (pl) 2002-08-30
EP0817640A1 (en) 1998-01-14
ES2200057T3 (es) 2004-03-01
EP0817640B1 (en) 2003-05-21
EE9700329A (et) 1998-06-15
JP4072646B2 (ja) 2008-04-09
NO974371L (no) 1997-11-20
BR9607538A (pt) 1998-01-06
CN1185111A (zh) 1998-06-17
CN1138551C (zh) 2004-02-18
PL322550A1 (en) 1998-02-02
WO1996029083A1 (en) 1996-09-26
AU5166596A (en) 1996-10-08
US6159465A (en) 2000-12-12
HK1017989A1 (en) 1999-12-10
AU702705B2 (en) 1999-03-04
NO974371D0 (no) 1997-09-22
CA2216150C (en) 2008-01-22
JPH11502703A (ja) 1999-03-09

Similar Documents

Publication Publication Date Title
SE9501056D0 (sv) Epithelial adherent lactobacilli
Coconnier et al. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion
Ogawa et al. Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA
Andersson et al. The adhesion of Bacillus cereus spores to epithelial cells might be an additional virulence mechanism
Delley et al. In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
FR2808689B1 (fr) Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
AU2613995A (en) Lactobacillus strains of human origin, their compositions and uses thereof
AU2002350530A1 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
HUP0200205A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
NZ335086A (en) Bacillus thuringiensis pesticidal toxins and nucleotide sequences which encode these toxins
ES2112818T1 (es) Composicion farmaceutica que comprende lactobacillus plantarum y arginina.
DK0858501T3 (da) Mælkesyrebakteriepræparater samt deres anvendelse til fremstilling af kolesterolsænkende produkter
Ouwehand et al. Specificity of spent culture fluids of Lactobacillus spp. to inhibit adhesion of enteropathogenic fimbriated Escherichia coli cells
WO2000067583A3 (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
Hryniewicz et al. The first national external quality assessment scheme in clinical bacteriology in Poland(POLMicro I)
MD20010076A (ro) Preparat microbian sanogenic pentru asanarea tubului digestiv şi tratamentul disbacteriozei
BG100214A (en) Method for probiotic preparation
GEP20033132B (en) Bacteriological Preparations
UA23320A (uk) Штам бактерій віfіdовастеrіuм lоnguм, який використовується у виробhицтві бактеріальhих препаратів та фермеhтоваhих молочhих продуктів